FXFangran Xin

Fangran Xin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fangran Xin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Autonomics, More Than Fibrosis, Predict Postoperative Atrial Fibrillation

    by Yuji Zhang, David G Benditt, Fangran Xin, Yufeng Chen, Jia Guo, Guannan Liu, Huaiyang Liu, Zongtao Yin, Sunny S. Po, Huishan Wang

    Background: Postoperative atrial fibrillation (POAF) is a common complication of cardiac surgery with POAF susceptibility thought to be primarily the result of pre-existing structural atrial disease, specifically fibrosis. We tested this hypothesis directly by combining preoperative imaging of atrial fibrosis with continuous physiological monitoring before POAF onset. Methods: This prospective single center study (2023–2025) comprised 6,697 adults without prior atrial fibrillation (AF) undergoing elective cardiac surgery. Subjects were enrolled into three prespecified, non-overlapping cohorts: a mechanistic imaging cohort (n=52) to test whether preoperative atrial fibroblast activation predicts POAF; a physiological monitoring cohort (n=3,183) to characterize peri-event autonomic dynamics via time-resolved HRV analysis; and an independent prospective observability cohort (n=3,451) for validation. The prespecified primary analyses assessed time-domain and frequency-domain HRV across six consecutive 10- minute intervals during the 60 minutes preceding POAF onset. Generalized estimating equations models were applied. Results: Preoperative atrial fibroblast activation did not differ significantly between patients with (n=22) or without POAF (n=52). By contrast, in a physiological monitoring cohort (n=3,183), time-resolved heart rate variability analysis revealed progressive autonomic destabilization beginning approximately 20 minutes before POAF onset, with significant divergence in heart-rate-corrected SDNN in the final 10-minute pre-event interval (marginal mean difference 0.0139, 95% CI 0.0113–0.0164; P<0.001; Cohen’s d=0.728). This signal was independently validated in a prospective observability cohort (n=3,451), achieving fragment-level sensitivity of 69.6% and specificity of 97.5% at the 10-minute horizon. Conclusions: POAF is more closely associated with immediately preceding detectable autonomic destabilization than with preoperative structural substrate. These findings challenge the hypothesis that POAF susceptibility is structurally determined(structural-determinism) and reframe this frequent complication as a dynamic, state-dependent process that may be a target for active prevention.

  • Open Access

    Robust Artificial Intelligence Tool for Atrial Fibrillation Diagnosis: Novel Development Approach Incorporating Both Atrial Electrograms and Surface ECG and Evaluation by Head‐to‐Head Comparison With Hospital‐Based Physician ECG Readers

    by Yuji Zhang, Shusheng Xu, Wenhui Xing, Qiong Chen, Xu Liu, Yachuan Pu, Fangran Xin, Hui Jiang, Zongtao Yin, Dengshun Tao, et al.

    Background: Atrial fibrillation (AF) increases risk of embolic stroke, and in postoperative patients, increases cost of care. Consequently, ECG screening for AF in high‐risk patients is important but labor‐intensive. Artificial intelligence (AI) may reduce AF detection workload, but AI development presents challenges. Methods and Results: We used a novel approach to AI development for AF detection using both surface ECG recordings and atrial epicardial electrograms obtained in postoperative cardiac patients. Atrial electrograms were used only to facilitate establishing true AF for AI development; this permitted the establishment of an AI‐based tool for subsequent AF detection using ECG records alone. A total of 5 million 30‐second epochs from 329 patients were annotated as AF or non‐AF by expert ECG readers for AI training and validation, while 5 million 30‐second epochs from 330 different patients were used for AI testing. AI performance was assessed at the epoch level as well as AF burden at the patient level. AI achieved an area under the receiver operating characteristic curve of 0.932 on validation and 0.953 on testing. At the epoch level, testing results showed means of AF detection sensitivity, specificity, negative predictive value, positive predictive value, and F1 (harmonic mean of positive predictive value and sensitivity) as 0.970, 0.814, 0.976, 0.776, and 0.862, respectively, while the intraclass correlation coefficient for AF burden detection was 0.952. At the patient level, AF burden sensitivity and positive predictivity were 96.2% and 94.5%, respectively. Conclusions: Use of both atrial electrograms and surface ECG permitted development of a robust AI‐based approach to postoperative AF recognition and AF burden assessment. This novel tool may enhance detection and management of AF, particularly in patients following operative cardiac surgery.


  • Open Access

    Unexpected Increase in Postoperative Atrial Fibrillation by Calcium-mediated Autonomic Denervation: Results of the CAP-AF2 Trial

    by Huishan Wang, Yuji Zhang, Fangran Xin, Jikai Zhao, Keyan Zhao, Dengshun Tao, Prayloy Chakraborty, Zongtao Yin, Guannan Liu, Sunny S. Po

    Background: In the CAP-AF trial, injection of calcium chloride (CaCl 2 ) into the four major atrial ganglionated plexi (GP) reduced the relative risk of postoperative atrial fibrillation (POAF) by 63% in patients undergoing coronary artery bypass surgery (CABG). Objective: The CAP-AF2 trial intended to investigate if similar autonomic denervation could prevent POAF in patients with mitral regurgitation (MR) but without persistent AF who underwent surgery for MR. Methods: The CAP-AF-2 trial was an investigator-initiated, single center, double-blind, randomized clinical trial. This trial planned to 1:1 randomize 320 adult patients to CaCl 2 vs. sodium chloride (NaCl, sham) injection into the four GP during surgery. The primary outcome was incidence of POAF (≥30 seconds) in 7 days. Secondary outcomes included length of hospitalization, POAF burden, actionable antiarrhythmic therapy for POAF, heart rate variability changes and plasma inflammatory markers. Results: This trial was terminated after midterm analysis showing that the cumulative POAF incidence was higher in the CaCl 2 group (43/78, 55.13%) than the NaCl group (31/82, 37.80%; confidence interval of difference 1.01%-32.48%, P = 0.028). In the CaCl 2 group, more patients were hospitalized over 7 days (69.8% vs. 45.2%; p=0.033) and more patients required amiodarone therapy (p=0.039). AF burden, plasma inflammatory markers and heart rate variability were not different between the two groups. Frequent atrial bigeminy or nonsustained atrial tachycardia immediately preceded POAF in 76.7% (CaCl 2 ) and 29.0% (NaCl) patients, respectively ( P The Chinese Clinical Trial Registry registration number: ChiCTR2000029314. website : http://www.chictr.org.cn/showproj.aspx?proj=48587 CLINICAL PERSPECTIVES: What is new: - Calcium-mediated autonomic denervation increased the incidence of post-operative atrial fibrillation (AF) in patient undergoing mitral valve surgery for severe mitral regurgitation, contradictory to the beneficial effects it exerted on patients undergoing coronary artery bypass surgery. Clinical implications: - Each cardiovascular disease may have its distinct autonomic balance at the tissue level. - Mechanisms underlying the initiation and maintenance of AF vary greatly among cardiovascular diseases; autonomic denervation therefore can be beneficial or harmful. - Autonomic denervation for each cardiovascular disease should only be performed with evidence from randomized clinical trials to demonstrate its efficacy and safety.

  • Preventive Effect of Berberine on Postoperative Atrial Fibrillation

    by Jian Zhang, Yang Wang, Hui Jiang, Dengshun Tao, Keyan Zhao, Zongtao Yin, Jinsong Han, Fangran Xin, Yan Jin, Huishan Wang

    Background: Postoperative atrial fibrillation (POAF) is one of the most common complications of cardiac surgery, but the underlying factors governing POAF are not well understood. The aim of this study was to investigate the efficacy of berberine administration on POAF. Methods: We conducted a randomized, double-blind, placebo-controlled trial with patients who underwent isolated coronary artery bypass grafting in China to study the impact of oral berberine on the incidence of POAF. A total of 200 patients who underwent coronary artery bypass grafting were randomized into the berberine group (n=100) and the placebo group (n=100). All patients underwent 7-day continuous telemetry and Holter monitoring. Results: The primary outcome was the incidence of POAF at 7 days. Secondary outcomes included clinical outcomes, POAF burden, intestinal endotoxin, and serum inflammatory biomarker levels. The POAF incidence was reduced from 35% to 20% under berberine treatment (hazard ratio, 0.5 [95% CI, 0.29–0.78]; P =0.0143). Perioperative mortality and morbidity did not differ between the 2 groups. POAF burden and the dose of amiodarone were significantly reduced in the berberine group. Oral berberine significantly decreased lipopolysaccharide, CRP (C-reactive protein), and IL (interleukin)-6 levels. Elevated lipopolysaccharide after surgery has been associated with POAF. Conclusions: Our results showed that administration of berberine may be effective for reducing the occurrence of POAF after coronary artery bypass grafting. Registration: URL: https://www.chictr.org.cn ; Unique identifier: ChiCTR2000028839.